On The Pen With Dave Knapp
Varighed i alt:
23 h 31 min
Stopping Zepbound and Maintaining with Revita
On The Pen With Dave Knapp
42:24
GLP-1 Treatment and Advocacy with Dr. Leslie Golden
On The Pen With Dave Knapp
77:07
Pfizer GLP-1 Play Worth $7.3B + Compound Tirzepatide Update
On The Pen With Dave Knapp
34:13
GLP-1 Weight Loss, Why It's About So Much More for Patients
On The Pen With Dave Knapp
50:03
Compound GLP-1 Legislation + FDA Warning Letter to HIMS
On The Pen With Dave Knapp
44:20
FDA CRACKDOWN on Compounded GLP-1s | Novo’s Gut Hack & Lilly’s One-Shot Cure
On The Pen With Dave Knapp
39:02
Is Wegovy Better Than Zepbound? Plus the First Obesity GLP-1 Generic is Here!
On The Pen With Dave Knapp
26:01
Zepbound Compound Lawsuit Update: Eli Lilly Vs Mochi
On The Pen With Dave Knapp
66:26
Eli Lilly VS Mochi Update + Big Lilly Orforglipron Secret Revealed
On The Pen With Dave Knapp
36:00
Ozempic Price Cut + New Obesity Pill Data
On The Pen With Dave Knapp
34:01
GLP-1 Microdosing For Weight Loss: Noom CEO Explains Their New Program
On The Pen With Dave Knapp
42:22
Eli Lilly Earnings Call Recap: Stock Tanks on Weight Loss Pill Miss
On The Pen With Dave Knapp
59:23
Novo Nordisk Blames Compound Semaglutide on Slower Sales
On The Pen With Dave Knapp
24:38
No Compounded Retatrutide Says the FDA + Tons of GLP-1 News
On The Pen With Dave Knapp
41:14
LEAKED TRUMP DOCUMENT: Medicare to Cover Zepbound and Wegovy for Obesity
On The Pen With Dave Knapp
26:46
Retatrutide Drops are Crazy // OTP TWD 7.29.25
On The Pen With Dave Knapp
33:17
Compound GLP-1 Injections : You Won't Believe What The Obesity Society is Saying
On The Pen With Dave Knapp
24:04
Connecticut Making Ozempic!? Meet The Mastermind
On The Pen With Dave Knapp
26:22
SHOCKING: How GLP-1 Protects the Heart Beyond Weight Loss // OTP TWD 7.25.25
On The Pen With Dave Knapp
20:20
BREAKING: Insurance Approving Mounjaro Over Zepbound!? What is Going On!?
On The Pen With Dave Knapp
17:34
Behind the Scenes of the Obesity Drug Battle | Obesity Action Coalition President Interview
On The Pen With Dave Knapp
35:23
Unlocking Zepbound Insurance Coverage + More GLP-1 Good News // otp twd 7.1.25
On The Pen With Dave Knapp
33:37
Lilly Could Lose Their Tirzepatide Patent! Plus ADA Coverage // OTP TWD 06.24.25
On The Pen With Dave Knapp
26:52
Faces of The Fight: The Jamie Selzler Story
On The Pen With Dave Knapp
57:43
Zepbound Vials Drop, Amycretin Surges, FDA Fast Track, and a Dangerous Trend // TWD 6.17.25
On The Pen With Dave Knapp
29:32
GLP-1 Access Progress + The Race for Less Frequent Dosing: OTP TWD 6.10.25
On The Pen With Dave Knapp
22:33
Lilly Makes Bold Move on GLP Dosing / 8x More Ozempic? / Wegovy Use in Teens
On The Pen With Dave Knapp
21:18
Trump Admin Setting Price Targets for Zepbound and Ozempic, Will Pharma Go Along?
On The Pen With Dave Knapp
29:47
Zepbound vs. Wegovy, CVS vs. Patients, and the Executive Order That Changes Everything
On The Pen With Dave Knapp
41:02
Compound Tirzepatide Lawsuit + PBM Reform Update // OTP TWD 5.6.25
On The Pen With Dave Knapp
26:31
CVS Drops Zepbound + Lilly Earnings Call Recap
On The Pen With Dave Knapp
33:37
Compound GLP-1 PubMed Data: What It Didn’t Tell Us
On The Pen With Dave Knapp
21:40
High Dose Semaglutide Incoming! How Much Will it Cost? // OTP TWD 4.22.25
On The Pen With Dave Knapp
18:45
Getting Insurance To Cover Skin Removal Surgery // OTP Eps 109
On The Pen With Dave Knapp
64:02
Counterfeit Ozempic at Pharmacies! // OTP TWD 4.15.25
On The Pen With Dave Knapp
14:43
GLP-1 Slow Responders: Dr Matthea Rentea // OTP Eps 108
On The Pen With Dave Knapp
68:01
Grow-Zempic!? These Students Discoverd a GLP-1 Plant!
On The Pen With Dave Knapp
19:08
Noom CEO Geoff Cook Interview: Wall Street Journal GLP-1 Cost Ad
On The Pen With Dave Knapp
27:58
GLP-1 Medicare Coverage: What is Going On // OTP TWD 04.08.2025
On The Pen With Dave Knapp
25:41
Are GLP-1 Meds For Life? Fractyl’s CEO Says “Not So Fast!”
On The Pen With Dave Knapp
27:35
